Feeling overrun by abdominal pain and diarrhea?
If you;ve tried Imodium and are still experiencing symptoms of abdominal pain and diarrhea, learn how you could be eligible to participate in a research study of an approved drug for Irritable Bowel Syndrome with diarrhea (IBS-D).
Local doctors are conducting a research study to evaluate eluxadoline, a medication that has been approved to treat irritable Bowel Syndrome with Diarrhea (IBS-D) in adults. The purpose of this tudy is to understand the safety and effectiveness of eluxadoline in people with IBS-D who report that prior use of Ioperamide (Imodium) did not provide adequate control of their symptoms.
Irritable bowel syndrome (IBS) is a common disorder that affects the large intestine (colon). Irritable bowel syndrome commonly causes cramping, abdominal pain, bloating, gas, diarrhea and constipation. IBS is a chronic condition that you will need to manage long term.
You may qualify if:
- Between 18-80 years of age
- Be diagnosed with IBS-D or have a history of abdominal pain and diarrhea consistent with a diagnosis of IBS-D
- Have used loperamide (Imodium) in the prior 12 months, and use of loperamide did not provide adequate control of your IBS-D Symptoms
Benefits of this Research Study
- All Study-related vists, test and treatments will be provided at no cost.
- In addition, compensation for study-related time and travel may be provided.